ad

DCM Q1 FY27 Results: Revenue Grows 15% to Rs 20 Crore, PAT Surges 2000% to Rs 42 Lakh

DCM Q1 FY27: Revenue Rs 20 Cr (+14.76% YoY). PAT Rs 0.42 Cr (+2000%). Gross profit Rs 1 Cr vs Rs 0.30 Cr. Consolidated. CMP Rs 82.76 on Aug 13.


14 Aug 20263:45 pm

DCM Q1 FY27 Results: Revenue Grows 15% to Rs 20 Crore, PAT Surges 2000% to Rs 42 Lakh

Quick Answer

DCM delivered a standout Q1 FY27, with consolidated revenue growing 14.76% to Rs 20 crore from Rs 17 crore in Q1 FY26, while PAT surged 2000% to Rs 0.42 crore from a near-zero Rs 0.02 crore in the year-ago quarter. Gross profit grew 267% to Rs 1 crore from Rs 0.30 crore. DCM Q1 FY27 results reflect a business where a small revenue increase has dramatically improved the profit picture, driven by crossing the gross profit breakeven threshold that was barely above zero in Q1 FY26.

DCM Q1 FY27 results showed the consolidated company posting revenue of Rs 20 crore, up 14.76% from Rs 17 crore in Q1 FY26. The modest revenue gain combined with a dramatic profitability improvement points to a business operating very close to its breakeven point where even a small revenue increase produces an outsized earnings improvement.

The DCM Q1 FY27 results showed gross profit growing 266.67% from Rs 0.30 crore to Rs 1 crore on 15% higher revenue, and PAT surging 2000% from Rs 0.02 crore to Rs 0.42 crore. The extreme profit improvement on modest revenue growth is explained by the fact that Q1 FY26 performance was at the very edge of profitability, and the additional Rs 3 crore of revenue pushed the company significantly above its break-even threshold.

Click Here – Get Free Investment Predictions

DCM Q1 FY27 Financial Highlights

Metric Q1 FY27 (Rs Crore) Q1 FY26 (Rs Crore) YoY Change
Revenue 20.00 17.00 +14.76%
Gross Profit 1.00 0.30 +266.67%
Net Profit / PAT 0.42 0.02 +2000%

DCM Q1 FY27 Performance Analysis

Use the Univest Screener to track DCM live financials and Q1 FY27 results

The 2000% PAT growth in DCM Q1 FY27 results on 15% revenue growth is best understood through the lens of operating leverage near the breakeven point. When a business is operating at marginal profitability, even a modest revenue increase produces mathematically extreme percentage gains in PAT, which is exactly what happened here.

Gross profit growing 267% from Rs 0.30 crore to Rs 1 crore in DCM Q1 FY27 results on Rs 3 crore additional revenue implies that approximately Rs 0.70 crore of the Rs 3 crore incremental revenue flowed to gross profit as incremental contribution. This gross contribution rate of approximately 23% on the incremental business is meaningful.

PAT of Rs 0.42 crore in DCM Q1 FY27 results represents a solid earnings base for a company of this scale. While the absolute amount is small, the dramatic improvement from near-zero Q1 FY26 earnings signals that the business is now consistently above its breakeven threshold.

For DCM, sustaining the current revenue scale and improving further toward Rs 22-25 crore quarterly would generate additional PAT growth through the same operating leverage mechanism that produced the strong Q1 FY27 results.

Key Business Factors in Q1 FY27

Revenue Above Breakeven Threshold

The 2000% PAT growth in DCM Q1 FY27 results demonstrates operating leverage near breakeven. With Q1 FY26 nearly at breakeven, the Rs 3 crore additional revenue in Q1 FY27 was almost entirely incremental contribution, explaining the outsized PAT improvement.

Gross Margin Normalisation

Gross profit growing 267% on 15% revenue in DCM Q1 FY27 results indicates that the low Q1 FY26 gross profit of Rs 0.30 crore was partially depressed by one-time factors or cost spikes that did not recur in Q1 FY27. The normalized gross margin improved significantly.

Cost Discipline on Revenue Growth

DCM Q1 FY27 results show the company managing its overhead structure effectively while growing revenue, allowing the gross profit improvement to flow through to PAT with high conversion efficiency.

Dividend Details

DCM has not declared a dividend for Q1 FY27. At PAT of Rs 0.42 crore quarterly, the company is retaining earnings for working capital and business development.

FY27 Outlook

The FY27 outlook for DCM is positive following the Q1 FY27 results improvement. If revenue can maintain the Rs 20 crore quarterly run-rate or grow modestly toward Rs 22-25 crore, the operating leverage should continue to deliver improving PAT through subsequent quarters.

Key risks include any revenue moderation back toward Rs 17 crore Q1 FY26 levels, which would compress PAT significantly given the operating leverage dynamics visible in DCM Q1 FY27 results.

DCM Stock Performance

Download the Univest iOS App or Univest Android App to track DCM share price live and stay updated on quarterly results.

DCM shares traded at Rs 82.76 on August 13, 2026, up 0.72% on the day. The stock's relative valuation should be assessed against the company's improving but still modest absolute PAT of Rs 0.42 crore per quarter.

Key Risks

Revenue Sensitivity

DCM Q1 FY27 results demonstrate extreme PAT leverage to revenue changes near the breakeven point. Any decline back toward Rs 17 crore quarterly revenue could see PAT compress very significantly given the fixed cost base.

Small Revenue Base

At Rs 20 crore quarterly revenue, DCM is a small company highly sensitive to individual customer or market changes. Maintaining and growing this revenue base in a competitive market is the central management challenge.

Gross Margin Sustainability

The improvement in gross margins from approximately 1.8% to 5% in DCM Q1 FY27 results is positive, but requires verification that the Q1 FY26 low was anomalous rather than reflecting a structural margin issue that has been temporarily resolved.

Conclusion

DCM Q1 FY27 results are impressive in percentage terms, with PAT growing 2000% to Rs 0.42 crore on 15% revenue growth to Rs 20 crore. The extreme percentage improvement reflects the operating leverage of a business crossing significantly above its breakeven threshold.

The absolute earnings base remains modest at Rs 0.42 crore PAT. Continued revenue growth and gross margin maintenance will be critical for DCM to build a consistently profitable earnings profile from Q1 FY27 results. Consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on DCM Q1 FY27 Results

When were DCM Q1 FY27 results announced?

Ans. DCM Q1 FY27 results were announced on August 13, 2026, covering the April to June 2026 quarter on a consolidated basis.

What was DCM's revenue in Q1 FY27?

Ans. DCM reported consolidated revenue of Rs 20 crore in Q1 FY27, up 14.76% from Rs 17 crore in Q1 FY26.

What was DCM's PAT in Q1 FY27?

Ans. DCM's net profit (PAT) was Rs 0.42 crore in Q1 FY27, up approximately 2000% from Rs 0.02 crore in Q1 FY26.

Why did DCM's PAT surge 2000% on only 15% revenue growth in Q1 FY27?

Ans. DCM Q1 FY27 results reflect extreme operating leverage near the breakeven point. With Q1 FY26 barely profitable at Rs 0.02 crore PAT, the Rs 3 crore additional revenue in Q1 FY27 produced an outsized PAT improvement by pushing the business significantly above breakeven.

Did DCM declare a dividend for Q1 FY27?

Ans. DCM has not declared a dividend for Q1 FY27.

What is the outlook for DCM after Q1 FY27 results?

Ans. The FY27 outlook is positive if DCM can sustain or grow its Rs 20 crore quarterly revenue run-rate. Operating leverage near breakeven means revenue stability is critical for maintaining the improved profitability.

Is DCM a good investment after Q1 FY27 results?

Ans. DCM Q1 FY27 results show impressive PAT growth but the absolute scale is small. Investors should assess revenue sustainability and competitive positioning. Consult a SEBI-registered advisor.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down